DUBLIN–(BUSINESS WIRE)–
Research and Markets (http://www.researchandmarkets.com/research/6jlq2t/levadex) has announced the addition of the “Levadex (Migraine) – Forecast and Market Analysis to 2023″ report to their offering.
The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth.
By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.
Levadex is being developed by Allergan as an acute therapy for migraine. Levadex is a member of the ergot alkaloids class of acute migraine treatment. It contains a reformulation of the drug dihydroergotamine mesylate (DHE) in a proprietary Tempo inhaler that allows DHE to be rapidly absorbed from the pleural mucosa into the systemic circulation. DHE has been used to treat migraine attacks for decades, administered by intravenous infusion or nasal sprays.
Key Topics Covered:
1 Table of Contents
2 Introduction
3 Disease Overview
4 Disease Management
5 Competitive Assessment
6 Opportunity and Unmet Need
7 Pipeline Assessment
8 Levadex
9 Appendix
For more information visit http://www.researchandmarkets.com/research/6jlq2t/levadex
- Personal Investing Ideas & Strategies
- Health
Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System
Did you find this useful? More Info: JustNoHeadache.com
